Your browser doesn't support javascript.
loading
Tyrosine Kinase Inhibitor Cabozantinib Inhibits Murine Renal Cancer by Activating Innate and Adaptive Immunity.
Liu, Hongyan; Sun, Shishuo; Wang, Gang; Lu, Mengmeng; Zhang, Xiaokang; Wei, Xiaohuan; Gao, Xiaoge; Huang, Chao; Li, Zhen; Zheng, Junnian; Zhang, Qing.
Afiliación
  • Liu H; Cancer Institute, Xuzhou Medical University, Xuzhou, China.
  • Sun S; Center of Clinical Oncology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Wang G; Cancer Institute, Xuzhou Medical University, Xuzhou, China.
  • Lu M; Center of Clinical Oncology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Zhang X; Cancer Institute, Xuzhou Medical University, Xuzhou, China.
  • Wei X; Center of Clinical Oncology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Gao X; Cancer Institute, Xuzhou Medical University, Xuzhou, China.
  • Huang C; Center of Clinical Oncology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Li Z; Cancer Institute, Xuzhou Medical University, Xuzhou, China.
  • Zheng J; Center of Clinical Oncology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Zhang Q; Cancer Institute, Xuzhou Medical University, Xuzhou, China.
Front Oncol ; 11: 663517, 2021.
Article en En | MEDLINE | ID: mdl-33954115
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article País de afiliación: China